RA Capital Management - MARINUS PHARMACEUTICALS INC ownership

MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 88 filers reported holding MARINUS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 3.53 and the average weighting 0.3%.

Quarter-by-quarter ownership
RA Capital Management ownership history of MARINUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$15,860,0001,300,0000.22%
Other shareholders
MARINUS PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Lion Point Capital, LP 2,145,337$17,269,9637.70%
Bleichroeder LP 1,872,463$15,073,3273.72%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,204,942$41,899,7832.26%
Opaleye Management Inc. 584,000$4,701,2001.53%
Bain Capital Life Sciences Investors, LLC 1,431,058$11,520,0171.29%
Cormorant Asset Management, LP 2,625,000$21,131,2501.23%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 290,000$2,337,4000.79%
Ikarian Capital, LLC 746,069$6,005,8560.72%
Eventide Asset Management 4,529,997$36,466,4760.66%
Altium Capital Management LP 125,033$1,006,5160.52%
View complete list of MARINUS PHARMACEUTICALS INC shareholders